Value of Cervical Cancer Diagnostic Tests Market estimated at US$ 13.6 Bn by 2031, TMR Study
29 Jun 2022
Immunotherapy
High risk of human papillomavirus infection to lead to cervical cancer impels demand for cervical cancer diagnostic tests for prevention of cervical cancer
North America to continue to remain key market with easy access to screening solutions and affordability for expensive diagnostic procedures
ALBANY, N.Y., June 29, 2022 /PRNewswire/ -- The cervical cancer diagnostic tests market is projected to expand at a CAGR of 4.6% for the forecast period from 2022 to 2031. Increasing prevalence of cervical cancer in women which is related to a number of causative factors propels the cervical cancer diagnostic tests market.
According to the World Health Organization, cervical cancer is the second most commonly prevalent cancer and the third-largest cause of death in women with 530,000 new cases each year. For example, in 2018, approximately 570, 000 women were diagnosed with cervical cancer globally and nearly 310, 000 deaths were reported related to the disease.
High incidence of human papillomavirus infection in women population and long-term use of oral contraceptives that are related to cervical cancer underscores demand for cervical cancer diagnostic tests.
Role of large pharmaceutical companies toward discovering improved treatment for cervical cancer is benefitting the cervical cancer diagnostic tests market. The introduction of technologically advanced computer-assisted cervical cancer screening tests to reduce shortcomings of predecessor tests and for improved accuracy contributes to the growth of cervical cancer diagnostic tests market.
Request Brochure of Cervical Cancer Diagnostic Tests Market Research Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=736
Cervical Cancer Diagnostic Tests Market – Key Findings of the Report
Increasing awareness for early stage diagnosis of cancer coupled with rising demand for advanced screening techniques are some key factors for ongoing trends of cervical cancer diagnostic tests market
Pap smear diagnostic test held the leading share of cervical cancer diagnostic tests market in 2021, and is anticipated to continue to remain at the fore during the forecast period. Increasing number of patients with high-risk human papillomavirus infection and increasing number of teenage sex are some key factors fuelling the growth of Pap smear diagnostic test segment.
Hospitals end-user segment accounted for key share of cervical cancer diagnostic tests market in 2021. Factors such as availability of multiple service options and tie-ups with healthcare companies for advanced medical devices makes hospitals preferred among patients. Nonetheless, specialty clinics segment is projected to expand at a significant growth rate especially in developed countries to offload burden on hospitals.
North America held the leading share of cervical cancer diagnostic tests market in 2021. Large baby boomer population that can afford expensive diagnostic tests and presence of some large diagnostic kits and device providers that enables easy access to screening solutions are creating opportunities in the cervical cancer diagnostic tests market of the region.
Increasing demand for preventive diagnostics in developing countries to account for significant growth of cervical cancer diagnostic tests market in Asia Pacific in the upcoming years
Diversification of product portfolio is a key growth strategy of companies in the cervical cancer diagnostic tests market. The launch of a human papillomavirus self-sampling testing kit from F. Hoffmann-La Roche Ltd for regions that accept CE mark is a significant cervical cancer diagnostic tests market development
Request for Analysis of COVID-19 Impact on Cervical Cancer Diagnostic Tests Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=736
Cervical Cancer Diagnostic Tests Market – Growth Drivers
Statistics of cervical cancer as the second most commonly prevalent and third-largest cause of death in women propels the cervical cancer diagnostic tests market
Increasing demand for advanced screening techniques for early stage diagnosis of cancer underscores growth of cervical cancer diagnostic tests market
Get Exclusive PDF Sample Copy of Cervical Cancer Diagnostic Tests Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=736
Cervical Cancer Diagnostic Tests Market – Key Players
Some of the key players operating in the cervical cancer diagnostic tests market are;
Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=736
The cervical cancer diagnostic tests market is segmented as follows;
Cervical Cancer Diagnostic Tests Market, by diagnostic test
Pap Smear Test
HPV Test
Colposcopy
Biopsy & Endocervical Curettage
Other diagnostic tests
Cervical Cancer Diagnostic Tests Market, by End-user
Hospitals
Others
Cervical Cancer Diagnostic Tests Market, by Region
North America
Europe
Latin America
Middle East & Africa
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Healthcare Industry Research Reports by Transparency Market Research:
Cancer ImmunotherapyCancer Immunotherapy Market: Increase in R&D activities, improvements in efficacy & accuracy of newer medicines, surge in adoption of target therapy over standard therapy, and rise in prevalence of cancer are the major factors propelling the global cancer immunotherapy market.
HER2 Breast Cancer Test Market: Rise in prevalence of breast cancer across the globe is projected to drive the global HER2 breast cancer test market during the forecast period. Breast cancer in women is a primary health burden globally.
Hyperthermia Cancer Treatment Market: The hyperthermia cancer treatment market is predicted to reach US$ 266 Mn by the end of 2030. The deep tissue thermal therapy is gaining prominence in the cancer treatment space, especially among patients with breast cancer.
Cancer DiagnosticsCancer Diagnostics Market: Increasing trend for preventive diagnosis due to escalating prevalence continues, early diagnosis enables better clinical and economical outcomes for patients are projected to drive the global cancer diagnostics market during the forecast period.
Breast CancerBreast Cancer Diagnostics Market: High prevalence and increase in incidence rate of breast cancer across the globe and technological advancements in diagnostic techniques are anticipated to fuel the growth of the global breast cancer diagnostics market.
Prostate Cancer TherapeuticsProstate Cancer Therapeutics Market: The prostate cancer therapeutics market was valued at ~US$ 10 Bn in 2019, and is projected to arrive at a value tantamount to ~US$ 19.6 Bn by 2027, expanding at a CAGR of ~8% during the period of 2019-2027.
Head and Neck Cancer Market: The global head and neck cancer market is driven by increase in the patient population, rise in health care infrastructure in developing economies, growth of the pharmaceutical industry, surge in research and development activity, increase in product approvals, and rise in government initiatives.
Anticancer Drugs Market: The increasing number of deaths caused due to cancer is a prime factor augmenting the growth of the global anticancer drugs market. Cancer is a gathering of sicknesses related with strange cell development with the possibility to torment or spread to different pieces of the body.
Transparency Market Research is a global market research company providing business custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]
Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
SOURCE Transparency Market Research
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Targets
Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.